Intertek to Exhibit and Present at 2018 AAPS PharmSci360

Intertek’s pharmaceutical team will exhibit at the 2018 AAPS PharmSci 360 taking place in Washington, DC. This is the first year for the new program and format that will focus on science, career and community, combining a large scientific audience with niche topics. Approximately 7,000 scientists will come together to network and learn about all aspects of the pharmaceutical sciences, including chemical and biomolecule entities and how they complement each other.

Intertek’s Laurence M. Brill, Ph.D., Principal Scientist - Protein and Bioanalytical LCMS, and Stephen Rundlett, Director of Biomarker Programs, will present a poster titled “Modern LC-MS/MS-based proteomics: Powerful tools for reliable discovery of biomarkers and biomedical mechanisms in drug development". Stop by to view the presentation and find out more from our experts!

Intertek’s experts in small and large molecule pharmaceuticals will be present at Booth 1108 to discuss all aspects of contract bioanalytical services, pharmaceutical development and current industry hot topics that present challenges for your business. We also look forward to further discussing the scientific tracks that will be covered at the conference, including Preclinical development, Bioanalytics, Clinical Pharmacology, Manufacturing and Bioprocessing, and Formulation and Quality.

REQUEST A MEETING

Learn more about the AAPS and PharmSci360
The mission of the AAPS is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health. The goal of the meeting is for participants to share and learn scientific information, expand their networks, and expand in areas that will lead to career-related growth and improve their work performance.